Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study

PURPOSE: To evaluate the blood pressure (BP) lowering efficacy and safety of CKD-828, a fixed-dose combination of S-amlodipine (the more active isomer of amlodipine besylate, which is calcium channel blocker) and telmisartan (long acting angiotensin receptor blocker), in patients with hypertension i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Ihm, Sang-Hyun, Jeon, Hui-Kyung, Cha, Tae-Joon, Hong, Taek-Jong, Kim, Sang-Hyun, Lee, Nae-Hee, Yoon, Jung Han, Yoon, Namsik, Hwang, Kyung-Kuk, Jo, Sang-Ho, Youn, Ho-Joong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125808/
https://ncbi.nlm.nih.gov/pubmed/27920497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S116847
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi